
Mizuho Senior Biotech Analyst Salim Syed highlights key companies in the news he covers heading into the new year
BiotechTV - News
00:00
Biogen upside and catalysts
Salim compares Biogen to past Gilead, noting multiple 2026 catalysts including a subcutaneous inducer and tau data.
Play episode from 23:42
Transcript


